Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction.

Goldenberg I, Vyas AK, Hall WJ, Moss AJ, Wang H, He H, Zareba W, McNitt S, Andrews ML; MADIT-II Investigators.

J Am Coll Cardiol. 2008 Jan 22;51(3):288-96. doi: 10.1016/j.jacc.2007.08.058.

2.

Reduction in ventricular tachyarrhythmias with statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.

Vyas AK, Guo H, Moss AJ, Olshansky B, McNitt SA, Hall WJ, Zareba W, Steinberg JS, Fischer A, Ruskin J, Andrews ML; MADIT-II Research Group.

J Am Coll Cardiol. 2006 Feb 21;47(4):769-73. Epub 2006 Jan 30. Erratum in: J Am Coll Cardiol. 2006 Apr 18;47(8):1739.

3.

Temporal aspects of improved survival with the implanted defibrillator (MADIT-II).

Moss AJ, Vyas A, Greenberg H, Case RB, Zareba W, Hall WJ, Brown MW, McNitt SA, Andrews ML; MADIT-II Research Group.

Am J Cardiol. 2004 Aug 1;94(3):312-5.

PMID:
15276094

Supplemental Content

Loading ...
Support Center